Goeddel David V's Form 4 filing
RAPT Therapeutics, Inc. (RAPT) · filed Sep 16, 2021
- Accession no.
- 0000899243-21-036293
- Filed
- Sep 16, 2021, 5:16 PM ET
- Trade date
- Sep 14-15, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 13 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.71M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goeddel David VCIK 0001182464 | 10% Owner |
| Column Group II, LPCIK 0001600420 | 10% Owner |
| Svennilson PeterCIK 0001606074 | 10% Owner |
| Kutzkey TimCIK 0001614186 | 10% Owner |
| Column Group II GP, LPCIK 0001645333 | 10% Owner |
| Ponoi Capital, LPCIK 0001707230 | 10% Owner |
| Ponoi Management, LLCCIK 0001720702 | 10% Owner |
| Ponoi Capital II, LPCIK 0001732601 | 10% Owner |
| Ponoi II Management, LLCCIK 0001746488 | 10% Owner |
| Column Group LLCCIK 0001833486 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 | Common Stock | SSaleDisposed | −1,400 | $35.71 | −$49,989.94 | 70,861 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −29,634 | $36.79 | −$1,090,142.99 | 41,227 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −25,351 | $37.27 | −$944,844.45 | 15,876 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −1,700 | $35.77 | −$60,814.44 | 70,617 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −42,151 | $36.92 | −$1,556,046.32 | 28,466 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −10,807 | $37.31 | −$403,261.04 | 17,659 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −1,496 | $35.75 | −$53,476.91 | 35,137 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −32,211 | $36.85 | −$1,187,065.54 | 2,926 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −2,926 | $37.31 | −$109,157.94 | 0 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −11,476 | $37.21 | −$427,065.57 | 4,400 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −4,400 | $37.67 | −$165,762.08 | 0 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −12,939 | $37.22 | −$481,633.57 | 4,720 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −4,720 | $37.70 | −$177,957.22 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.